CD274 and esophageal squamous cell carcinoma: In summary, the current study aims to explore the efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of ESCC and identify factors influencing therapeutic outcomes through a meta-analysis of multiple phase III RCTs.